In order to respond to increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine German biotechnology company BioNTech is planni
In order to respond to increased global demand, we plan to manufacture two billion doses of our COVID-19 vaccine German biotechnology company BioNTech is planni